General Surgery Devices Market Will Reach $17.5 Billion By 2024: Grand View Research, Inc.

The global general surgery devices market was valued at USD 7.0 billion in 2015 and is expected to reach a value of USD 17.5 billion by 2024, based on a new study by Grand View Research, Inc. The growth of the market is attributed to the increasing geriatric population base, government support and continual technological advancements launched by the key players. Demand for advanced devices is growing steadily due to heightened awareness levels of newer technologies and the subsequent increase in the adoption of minimally invasive and computer-assisted treatments.

Technological development in the industry is favoring the emergence of minimally invasive procedures, thereby increasing patient safety and shortening hospital stays. Several technological changes have been witnessed in varied segments of abdominal and hernia surgeries; cardiac, trauma and burn surgeries; and in breast and plastic surgeries. For instance, thymectomy is a newly developed procedure for my asthenia gravis patients.

Globally, rise in the number of procedures is one of the key factors driving the overall market. According to a study, general surgery accounts for an average 8% of all procedures in ambulatory surgical centers nationwide.

Browse full research report on Global General Surgery Devices Market: http://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market

Further Key Findings from the Study Suggest:

  • By product, disposable surgical supplies accounted for the highest market share in 2015 due to the growing demand for disposable products, rise in overall number of surgeries, and their comparatively high one-time cost as compared to reusable products.
  • Orthopedic surgery devices accounted for the largest share in 2015 due to an increase in global geriatric population and high incidence of bone diseases such as osteoporosis and arthritis.
  • Geographically, North America accounted for the highest share due to a large number of surgical procedures performed in the region. This is attributed to the presence of a considerably-sized geriatric population, rising prevalence of lifestyle-associated diseases, presence of major market players, and government initiatives supporting advancements in surgeries.
  • Asia Pacific is expected to grow at the maximum rate during the forecast period due to increasing investment by several companies, government-led supportive initiatives promoting the growth of this sector, and growing patient affordability.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the general surgery devices market by product, application and region:

General Surgery Devices Product Outlook (USD Million), 2013 - 2024
  • Disposable Surgical Supplies
  • Open Surgery Instruments
  • Energy-based & Powered Instruments
    • Electrosurgery
    • Thermal Ablation
    • Powered Instrument
  • Minimally Invasive Surgery Instruments
  • Medical Robotics & Computer-assisted Surgery Devices
  • Adhesion Prevention Products
General Surgery Devices Application Outlook (USD Million), 2013 - 2024 
  • Orthopedic Surgery
  • Cardiology
  • Minimal Invasive Surgery
  • Ophthalmology
  • Wound Care
  • Audiology
  • Thoracic Surgery
  • Urology and Gynecology Surgery
  • Plastic Surgery
  • Neurosurgery
  • Other
General Surgery Devices Regional Outlook (USD Million), 2013 - 2024
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-general-surgery-devices-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc

For more information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more